ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,182.96
-0.85%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,427.685
0.23%
Brent Oil
84.06
-0.33%
Bitcoin
64,660.42
-0.29%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Onyx Pharmaceuticals, Inc. (MM) (ONXX)

  7. Onyx Pharmaceuticals, Inc. (MM) (ONXX) News

Onyx Pharmaceuticals, Inc. (MM) (ONXX)

Onyx Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONXX
DateTimeSourceHeadlineSymbolCompany
27/08/201323:09Business WireRigrodsky & Long, P.A. Announces Investigation Of Onyx Pharmaceuticals, Inc. BuyoutNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201321:33Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201316:15Dow Jones NewsCorrection to Bayer, Onyx FDA Priority Review StoryNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201315:47PR Newswire (US)Ryan & Maniskas, LLP Announces Investigation of Onyx Pharmaceuticals, Inc.NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201312:19Business WireONYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiducia...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201312:00Dow Jones NewsBayer, Onxy Get FDA Priority Review for Sorafenib For Type of CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201308:15Dow Jones NewsBayer: FDA Priority Review for Nexavar Treatment of Thyroid CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201307:30PR Newswire (US)Bayer and Onyx Pharmaceuticals Announce FDA Priority Review Designation of Nexavar® (sorafenib) Supplemental New Drug Applic...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201302:36PR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Ony...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
27/08/201301:38PR Newswire (US)Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareh...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201322:14Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201321:42Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Turn Lower After Syria TalkNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201321:38Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201321:11Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Turn Lower After Debt-limit ReportNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201320:53Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Turn Lower In Low VolumeNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201320:20Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Edge Up; Durables Drop Alters Fed BetsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201319:44Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Edge Up; Durables Drop Alters Fed BetsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201319:02Business WireRigrodsky & Long, P.A. Announces Investigation Of Onyx Pharmaceuticals, Inc. BuyoutNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201319:02Business WireONYX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiducia...NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201318:13Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Rise On Fed Bets After Downbeat DataNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201318:04Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Rise On Fed Bets After Downbeat DataNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201317:54Business WireOnyx Pharmaceuticals Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Merger with Amgen, Inc.NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201317:47PR Newswire (US)Onyx Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By AmgenNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201316:47Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Rise On Fed Bets After Downbeat DataNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201316:17Dow Jones NewsMARKET SNAPSHOT: U.S. Stocks Rise On Fed Bets After Downbeat DataNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201316:07Business WireLaw Firm Brower Piven Announces Investigation of Onyx Pharmaceuticals, Inc. Proposed BuyoutNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201315:03ZacksTaper Coming Despite Weak Data? - Ahead of Wall StreetNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201311:16Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201311:08Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
26/08/201311:06Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ONXX

Your Recent History

BIT
P20EB1
NLBNPIT20EB1 20351221 0....
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved